应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
RVPH Reviva Pharmaceuticals Holdings, Inc.
休市中 05-17 16:00:00 EDT
1.67
-0.04
-2.34%
盘后
1.64
-0.03
-1.80%
19:59 EDT
最高
1.72
最低
1.62
成交量
30.69万
今开
1.71
昨收
1.71
日振幅
5.85%
总市值
4,662万
流通市值
3,530万
总股本
2,792万
成交额
51.17万
换手率
1.45%
流通股本
2,114万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
美国研究综述-AN2 Therapeutics、艺康公司、RPM 国际公司
Reuters · 05-16
美国研究综述-AN2 Therapeutics、艺康公司、RPM 国际公司
Reviva Pharmaceuticals Holdings, Inc.盘中异动 大幅上涨5.34%
自选股智能写手 · 05-15
Reviva Pharmaceuticals Holdings, Inc.盘中异动 大幅上涨5.34%
Reviva Pharmaceuticals Holdings, Inc. 公布截至 3 月的季度业绩 - 收益摘要
Reuters · 05-15
Reviva Pharmaceuticals Holdings, Inc. 公布截至 3 月的季度业绩 - 收益摘要
Reviva Pharmaceuticals Holdings, Inc.盘中异动 急速拉升5.03%报1.96美元
自选股智能写手 · 05-13
Reviva Pharmaceuticals Holdings, Inc.盘中异动 急速拉升5.03%报1.96美元
Reviva Pharmaceuticals Holdings, Inc.盘中异动 急速下跌5.14%
自选股智能写手 · 05-11
Reviva Pharmaceuticals Holdings, Inc.盘中异动 急速下跌5.14%
Reviva Pharmaceuticals Holdings, Inc.盘中异动 早盘大幅上涨6.07%报2.97美元
自选股智能写手 · 05-08
Reviva Pharmaceuticals Holdings, Inc.盘中异动 早盘大幅上涨6.07%报2.97美元
Reviva Pharmaceuticals Holdings, Inc.盘中异动 股价大涨5.69%
自选股智能写手 · 05-01
Reviva Pharmaceuticals Holdings, Inc.盘中异动 股价大涨5.69%
Reviva Pharmaceuticals Holdings, Inc.盘中异动 急速跳水6.25%报3.00美元
自选股智能写手 · 04-19
Reviva Pharmaceuticals Holdings, Inc.盘中异动 急速跳水6.25%报3.00美元
Benchmark:重申Reviva Pharmaceuticals(RVPH.US)评级,由Speculative Buy调整至Speculative Buy评级, 目标价17.00美元。
智通财经 · 04-16
Benchmark:重申Reviva Pharmaceuticals(RVPH.US)评级,由Speculative Buy调整至Speculative Buy评级, 目标价17.00美元。
Reviva Pharmaceuticals Holdings, Inc.盘中异动 急速下挫5.17%报3.30美元
自选股智能写手 · 04-16
Reviva Pharmaceuticals Holdings, Inc.盘中异动 急速下挫5.17%报3.30美元
Reviva Pharmaceuticals Holdings, Inc.盘中异动 大幅下挫7.05%
自选股智能写手 · 04-15
Reviva Pharmaceuticals Holdings, Inc.盘中异动 大幅下挫7.05%
Reviva Pharmaceuticals Holdings, Inc.盘中异动 早盘快速下跌5.25%
自选股智能写手 · 04-05
Reviva Pharmaceuticals Holdings, Inc.盘中异动 早盘快速下跌5.25%
Reviva Pharmaceuticals Holdings, Inc.盘中异动 股价大涨5.74%
自选股智能写手 · 04-04
Reviva Pharmaceuticals Holdings, Inc.盘中异动 股价大涨5.74%
Reviva Pharmaceuticals Holdings, Inc.盘中异动 大幅拉升5.17%报3.65美元
自选股智能写手 · 04-04
Reviva Pharmaceuticals Holdings, Inc.盘中异动 大幅拉升5.17%报3.65美元
Reviva Pharmaceuticals Holdings, Inc.盘中异动 股价大涨5.74%
自选股智能写手 · 03-27
Reviva Pharmaceuticals Holdings, Inc.盘中异动 股价大涨5.74%
Reviva Pharmaceuticals Holdings, Inc.盘中异动 早盘股价大涨5.73%
自选股智能写手 · 03-26
Reviva Pharmaceuticals Holdings, Inc.盘中异动 早盘股价大涨5.73%
Reviva Pharmaceuticals Holdings, Inc. 预计每股亏损35美分 - 财报前瞻
Reuters · 03-26
Reviva Pharmaceuticals Holdings, Inc. 预计每股亏损35美分 - 财报前瞻
Reviva Pharmaceuticals Holdings, Inc.盘中异动 下午盘股价大涨5.19%
自选股智能写手 · 03-26
Reviva Pharmaceuticals Holdings, Inc.盘中异动 下午盘股价大涨5.19%
Reviva Pharmaceuticals Holdings, Inc.盘中异动 临近收盘快速上涨5.07%报2.90美元
自选股智能写手 · 03-23
Reviva Pharmaceuticals Holdings, Inc.盘中异动 临近收盘快速上涨5.07%报2.90美元
Reviva Pharmaceuticals Holdings, Inc.盘中异动 股价大跌5.28%
自选股智能写手 · 03-21
Reviva Pharmaceuticals Holdings, Inc.盘中异动 股价大跌5.28%
公司概况
公司名称:
Reviva Pharmaceuticals Holdings, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Reviva Pharmaceuticals Holdings, Inc.于2018年3月20日在英属维尔京群岛注册成立。该公司是一家后期制药公司,致力于发现、开发并寻求将下一代治疗方法商业化,以治疗那些对社会、患者及其家庭具有重大未满足医疗需求和负担的疾病。他们目前的产品线主要集中在中枢神经系统、炎症和心脏代谢疾病。
发行价格:
--
{"stockData":{"symbol":"RVPH","market":"US","secType":"STK","nameCN":"Reviva Pharmaceuticals Holdings, Inc.","latestPrice":1.67,"timestamp":1715976000000,"preClose":1.71,"halted":0,"volume":306917,"hourTrading":{"tag":"盘后","latestPrice":1.64,"preClose":1.67,"latestTime":"19:59 EDT","volume":5285,"amount":8795.27,"timestamp":1715990372128},"delay":0,"floatShares":21139620,"shares":27918560,"eps":-1.548303,"marketStatus":"休市中","marketStatusCode":7,"change":-0.04,"latestTime":"05-17 16:00:00 EDT","open":1.71,"high":1.72,"low":1.62,"amount":511664.7681704,"amplitude":0.05848,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.548303,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1716192000000},"adr":0,"adjPreClose":1.71,"preHourTrading":{"tag":"盘前","latestPrice":1.7,"preClose":1.71,"latestTime":"08:49 EDT","volume":358,"amount":591.2721914,"timestamp":1715950172093},"postHourTrading":{"tag":"盘后","latestPrice":1.64,"preClose":1.67,"latestTime":"19:59 EDT","volume":5285,"amount":8795.27,"timestamp":1715990372128},"volumeRatio":0.6630801682971333},"requestUrl":"/m/hq/s/RVPH/wiki","defaultTab":"wiki","newsList":[{"id":"2435429736","title":"美国研究综述-AN2 Therapeutics、艺康公司、RPM 国际公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2435429736","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2435429736?lang=zh_cn&edition=full","pubTime":"2024-05-16 14:53","pubTimestamp":1715842434,"startTime":"0","endTime":"0","summary":" 路透5月16日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价,其中包括 AN2 Therapeutics、艺康和 RPM International。要闻 * AN2 Therapeutics Inc :Evercore ISI将目标价从7美元下调至2美元 * Biolife Solutions Inc :Maxim Group将目标价从25美元上调至30美元 * Ecolab Inc :Evercore ISI将目标价从195美元上调至250美元 * RPM International Inc :Evercore ISI 将目标价从 110 美元上调至 130 美元 * Third Harmonic Bio Inc :杰富瑞将目标价从8.1美元上调至15美元 以下是路透周四报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2435528675","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 大幅上涨5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435528675","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435528675?lang=zh_cn&edition=full","pubTime":"2024-05-15 03:52","pubTimestamp":1715716367,"startTime":"0","endTime":"0","summary":"北京时间2024年05月15日03时52分,Reviva Pharmaceuticals Holdings, Inc.股票出现异动,股价急速拉升5.34%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中,整体涨幅为0.47%。其相关个股中,Humacyte Inc C/Wts 27/08/2026 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、康乃德生物涨幅较大,Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.、Scorpius Holdings, Inc.较为活跃,换手率分别为193.16%、65.70%、46.67%,振幅较大的相关个股有Transcode Therapeutics, Inc.、Tc Biopharm Plc C/Wts 10/02/2028 、Sab Biotherapeutics Inc C/Wts 22/10/2026 ,振幅分别为69.43%、65.81%、53.25%。Reviva Pharmaceuticals Holdings, Inc.公司简介:Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司,致力于发现、开发并寻求商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405150352477a59dd3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405150352477a59dd3b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435390540","title":"Reviva Pharmaceuticals Holdings, Inc. 公布截至 3 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2435390540","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2435390540?lang=zh_cn&edition=full","pubTime":"2024-05-15 03:48","pubTimestamp":1715716103,"startTime":"0","endTime":"0","summary":" * Reviva Pharmaceuticals Holdings, Inc. 报告了截至3月底的季度调整后每股亏损25美分,高于去年同期的每股-30美分。三位分析师对该季度的平均预期是每股亏损 38 美分。* Reviva Pharmaceuticals Holdings, Inc. 公布的季度每股收益为亏损 25 美分。* Reviva Pharmaceuticals Holdings, Inc. 本季度股价下跌了 55.0%,今年迄今为止下跌了 67.0%。5月14日 - 预测变化 * 在过去三个月里,分析师的平均盈利预期下降了约 13%。华尔街对 Reviva Pharmaceuticals Holdings, Inc. 的 12 个月目标价中位数为 16.50 美元。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2435373806","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 急速拉升5.03%报1.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435373806","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435373806?lang=zh_cn&edition=full","pubTime":"2024-05-13 21:40","pubTimestamp":1715607600,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日21时40分,Reviva Pharmaceuticals Holdings, Inc.股票出现波动,股价快速上涨5.03%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中,整体涨幅为1.02%。其相关个股中,Nutriband Inc C/Wts 、Jasper Therapeutics Inc C/Wts 24/09/2026 、Ac Immune Sa涨幅较大,Allarity Therapeutics, Inc.、Cardio Diagnostics Holdings Inc.、Ac Immune Sa较为活跃,换手率分别为29.60%、17.41%、14.63%,振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Tevogen Bio Holdings Inc.、Ac Immune Sa,振幅分别为26.92%、23.36%、22.08%。Reviva Pharmaceuticals Holdings, Inc.公司简介:Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司,致力于发现、开发并寻求商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051321400087e8783e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051321400087e8783e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434786993","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 急速下跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434786993","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434786993?lang=zh_cn&edition=full","pubTime":"2024-05-11 00:19","pubTimestamp":1715357961,"startTime":"0","endTime":"0","summary":"北京时间2024年05月11日00时19分,Reviva Pharmaceuticals Holdings, Inc.股票出现异动,股价大幅下跌5.14%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中,整体涨幅为0.07%。其相关个股中,诺瓦瓦克斯医药、Clene Inc C/Wts 30/12/2025 、Iteos Therapeutics, Inc.涨幅较大,Transcode Therapeutics, Inc.、诺瓦瓦克斯医药、Allarity Therapeutics, Inc.较为活跃,换手率分别为192.29%、94.08%、52.70%,振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Estrella Immunopharma Inc C/Wts 29/09/2028、Cardio Diagnostics Holdings Inc.,振幅分别为77.01%、70.00%、53.60%。Reviva Pharmaceuticals Holdings, Inc.公司简介:Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司,致力于发现、开发并寻求商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405110019217a594440&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405110019217a594440&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433720844","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 早盘大幅上涨6.07%报2.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433720844","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433720844?lang=zh_cn&edition=full","pubTime":"2024-05-08 22:47","pubTimestamp":1715179666,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日22时47分,Reviva Pharmaceuticals Holdings, Inc.股票出现波动,股价快速上涨6.07%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中,整体涨幅为0.33%。其相关个股中,Sab Biotherapeutics Inc C/Wts 22/10/2026 、Effector Therapeutics Inc C/Wts 31/12/2025 、Nanoviricides, Inc.涨幅较大,Enveric Biosciences, Inc.、Allarity Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃,换手率分别为233.77%、68.58%、28.60%,振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd,振幅分别为60.74%、43.00%、38.21%。Reviva Pharmaceuticals Holdings, Inc.公司简介:Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司,致力于发现、开发并寻求商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050822474779268c2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050822474779268c2a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432370095","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 股价大涨5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432370095","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432370095?lang=zh_cn&edition=full","pubTime":"2024-05-01 00:24","pubTimestamp":1714494298,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日00时24分,Reviva Pharmaceuticals Holdings, Inc.股票出现异动,股价大幅拉升5.69%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中,整体涨幅为0.25%。其相关个股中,Eliem Therapeutics, Inc、Cyclacel Pharmaceuticals, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 涨幅较大,Cyclacel Pharmaceuticals, Inc.、Biorestorative Therapies, Inc.、Jaguar Health, Inc.较为活跃,换手率分别为1389.38%、229.98%、26.22%,振幅较大的相关个股有Eliem Therapeutics, Inc、Lexaria Bioscience Corp C/Wts 14/01/2026 、Cassava Sciences Inc C/Wts 15/11/2024,振幅分别为49.20%、48.00%、46.79%。Reviva Pharmaceuticals Holdings, Inc.公司简介:Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司,致力于发现、开发并寻求商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050100245879258d7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050100245879258d7b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428510755","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 急速跳水6.25%报3.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428510755","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428510755?lang=zh_cn&edition=full","pubTime":"2024-04-19 01:21","pubTimestamp":1713460867,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日01时21分,Reviva Pharmaceuticals Holdings, Inc.股票出现异动,股价大幅下挫6.25%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中,整体跌幅为0.63%。Reviva Pharmaceuticals Holdings, Inc.公司简介:Reviva Pharmaceuticals Holdings Inc 是一家临床阶段的制药公司,致力于发现、开发疾病治疗药物并寻求将其商业化。该信息摘要如下:Benchmark:重申Reviva Pharmaceuticals评级,由Speculative Buy调整至Speculative Buy评级, 目标价17.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404190121087a53d159&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404190121087a53d159&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427873388","title":"Benchmark:重申Reviva Pharmaceuticals(RVPH.US)评级,由Speculative Buy调整至Speculative Buy评级, 目标价17.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2427873388","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2427873388?lang=zh_cn&edition=full","pubTime":"2024-04-16 22:05","pubTimestamp":1713276358,"startTime":"0","endTime":"0","summary":"Benchmark:重申Reviva Pharmaceuticals(RVPH.US)评级,由Speculative Buy调整至Speculative Buy评级, 目标价17.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041622060187847ebf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041622060187847ebf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427878822","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 急速下挫5.17%报3.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427878822","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427878822?lang=zh_cn&edition=full","pubTime":"2024-04-16 21:39","pubTimestamp":1713274747,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日21时39分,Reviva Pharmaceuticals Holdings, Inc.股票出现波动,股价急速下跌5.17%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中,整体跌幅为0.52%。其相关个股中,Jaguar Health, Inc.、Cullinan Oncology, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大,Biorestorative Therapies, Inc.、Soligenix, Inc.、Jaguar Health, Inc.较为活跃,换手率分别为98.75%、31.60%、29.98%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Brainstorm Cell Therapeutics Inc.、Marinus Pharmaceuticals, Inc.,振幅分别为101.56%、21.87%、20.00%。Reviva Pharmaceuticals Holdings, Inc.公司简介:Reviva Pharmaceuticals Holdings Inc 是一家临床阶段的制药公司,致力于发现、开发疾病治疗药物并寻求将其商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240416213908861e64fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240416213908861e64fe&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427006724","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 大幅下挫7.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427006724","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427006724?lang=zh_cn&edition=full","pubTime":"2024-04-15 21:30","pubTimestamp":1713187845,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日21时30分,Reviva Pharmaceuticals Holdings, Inc.股票出现异动,股价快速跳水7.05%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中,整体跌幅为1.34%。其相关个股中,Soligenix, Inc.、Organovo Holdings, Inc.、Longeveron Inc.涨幅较大,Allarity Therapeutics, Inc.、Soligenix, Inc.、Longeveron Inc.较为活跃,换手率分别为575.26%、327.00%、246.72%,振幅较大的相关个股有Pluri Inc.、Sol-Gel Technologies Ltd.、Cg Oncology, Inc.,振幅分别为6.96%、6.78%、5.19%。Reviva Pharmaceuticals Holdings, Inc.公司简介:Reviva Pharmaceuticals Holdings Inc 是一家临床阶段的制药公司,致力于发现、开发疾病治疗药物并寻求将其商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415213045861e5cbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415213045861e5cbf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425056749","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 早盘快速下跌5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425056749","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425056749?lang=zh_cn&edition=full","pubTime":"2024-04-05 23:23","pubTimestamp":1712330636,"startTime":"0","endTime":"0","summary":"北京时间2024年04月05日23时23分,Reviva Pharmaceuticals Holdings, Inc.股票出现波动,股价大幅下跌5.25%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中,整体涨幅为0.68%。其相关个股中,Revolution Medicines Inc C/Wts 17/12/2026 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Moolec Science Sa C/Wts 涨幅较大,Candel Therapeutics, Inc.、Protara Therapeutics, Inc.、Tc Biopharm Plc较为活跃,换手率分别为129.34%、66.02%、39.92%,振幅较大的相关个股有Candel Therapeutics, Inc.、Tc Biopharm Plc C/Wts 10/02/2028 、Protara Therapeutics, Inc.,振幅分别为45.63%、41.39%、40.80%。Reviva Pharmaceuticals Holdings, Inc.公司简介:Reviva Pharmaceuticals Holdings Inc 是一家临床阶段的制药公司,致力于发现、开发疾病治疗药物并寻求将其商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404052323567a5114f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404052323567a5114f7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424174392","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 股价大涨5.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424174392","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424174392?lang=zh_cn&edition=full","pubTime":"2024-04-04 21:36","pubTimestamp":1712237815,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日21时36分,Reviva Pharmaceuticals Holdings, Inc.股票出现异动,股价大幅拉升5.74%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中,整体涨幅为0.48%。其相关个股中,Tc Biopharm Plc、Tevogen Bio Holdings Inc.、Tc Biopharm Plc C/Wts 10/02/2028 涨幅较大,Tc Biopharm Plc、Effector Therapeutics, Inc.、Candel Therapeutics, Inc.较为活跃,换手率分别为1034.29%、34.69%、18.07%,振幅较大的相关个股有Tc Biopharm Plc、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Tevogen Bio Holdings Inc.,振幅分别为63.08%、42.86%、24.04%。Reviva Pharmaceuticals Holdings, Inc.公司简介:Reviva Pharmaceuticals Holdings Inc 是一家临床阶段的制药公司,致力于发现、开发疾病治疗药物并寻求将其商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404213655861e3669&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404213655861e3669&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424829197","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 大幅拉升5.17%报3.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424829197","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424829197?lang=zh_cn&edition=full","pubTime":"2024-04-04 00:13","pubTimestamp":1712160825,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日00时13分,Reviva Pharmaceuticals Holdings, Inc.股票出现异动,股价快速拉升5.17%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中,整体涨幅为0.28%。其相关个股中,Kintara Therapeutics, Inc.、方舟生物医药、Vanda Pharmaceuticals Inc.涨幅较大,Kintara Therapeutics, Inc.、方舟生物医药、Vanda Pharmaceuticals Inc.较为活跃,换手率分别为505.78%、463.92%、71.61%,振幅较大的相关个股有Kintara Therapeutics, Inc.、方舟生物医药、珐博进,振幅分别为97.51%、58.48%、44.44%。Reviva Pharmaceuticals Holdings, Inc.公司简介:Reviva Pharmaceuticals Holdings Inc 是一家临床阶段的制药公司,致力于发现、开发疾病治疗药物并寻求将其商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404040013457a50fc29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404040013457a50fc29&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422280992","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 股价大涨5.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422280992","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422280992?lang=zh_cn&edition=full","pubTime":"2024-03-27 21:30","pubTimestamp":1711546235,"startTime":"0","endTime":"0","summary":"北京时间2024年03月27日21时30分,Reviva Pharmaceuticals Holdings, Inc.股票出现异动,股价大幅上涨5.74%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中,整体涨幅为0.31%。其相关个股中,Ibio, Inc.、Lixte Biotechnology Holdings, Inc.、Nutriband Inc.涨幅较大,Ibio, Inc.、Lixte Biotechnology Holdings, Inc.、Hoth Therapeutics, Inc.较为活跃,换手率分别为784.79%、286.22%、48.36%,振幅较大的相关个股有Ibio, Inc.、Carisma Therapeutics, Inc.、Bioatla, Inc.,振幅分别为16.52%、4.13%、3.65%。Reviva Pharmaceuticals Holdings, Inc.公司简介:Reviva Pharmaceuticals Holdings Inc 是一家临床阶段的制药公司,致力于发现、开发疾病治疗药物并寻求将其商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240327213036791d4b0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240327213036791d4b0a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422157146","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 早盘股价大涨5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422157146","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422157146?lang=zh_cn&edition=full","pubTime":"2024-03-26 21:40","pubTimestamp":1711460421,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日21时40分,Reviva Pharmaceuticals Holdings, Inc.股票出现波动,股价快速上涨5.73%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中,整体涨幅为0.25%。其相关个股中,Stoke Therapeutics, Inc.、Abvc Biopharma, Inc.、180 Life Sciences Corp C/Wts 07/11/2025涨幅较大,Abvc Biopharma, Inc.、Stoke Therapeutics, Inc.、Altamira Therapeutics Ltd.较为活跃,换手率分别为125.54%、18.90%、13.36%,振幅较大的相关个股有Stoke Therapeutics, Inc.、Bio-Path Holdings, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为29.69%、21.43%、16.01%。Reviva Pharmaceuticals Holdings, Inc.公司简介:Reviva Pharmaceuticals Holdings Inc 是一家临床阶段的制药公司,致力于发现、开发疾病治疗药物并寻求将其商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032621402187e7bd9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032621402187e7bd9f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422189690","title":"Reviva Pharmaceuticals Holdings, Inc. 预计每股亏损35美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2422189690","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2422189690?lang=zh_cn&edition=full","pubTime":"2024-03-26 20:38","pubTimestamp":1711456722,"startTime":"0","endTime":"0","summary":" * Reviva Pharmaceuticals Holdings, Inc. 预计在3月28日公布截至2023年12月31日的业绩时,季度收入将没有变化(预计)。* * LSEG分析师对Reviva Pharmaceuticals Holdings, Inc.的平均预期是每股亏损35美分。* 华尔街对 Reviva Pharmaceuticals Holdings, Inc. 的 12 个月目标价中位数为 17.00 美元,高于其上一次收盘价 3.14 美元。3月26日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2422526673","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 下午盘股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422526673","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422526673?lang=zh_cn&edition=full","pubTime":"2024-03-26 01:23","pubTimestamp":1711387430,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日01时23分,Reviva Pharmaceuticals Holdings, Inc.股票出现波动,股价急速拉升5.19%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中,整体涨幅为0.11%。其相关个股中,Landos Biopharma, Inc.、Clene Inc C/Wts 30/12/2025 、Altamira Therapeutics Ltd.涨幅较大,Altamira Therapeutics Ltd.、Xtl生物制药、Salarius Pharmaceuticals, Inc.较为活跃,换手率分别为3229.57%、443.44%、76.74%,振幅较大的相关个股有Xtl生物制药、Altamira Therapeutics Ltd.、Zura Bio Limited,振幅分别为78.61%、74.57%、47.80%。Reviva Pharmaceuticals Holdings, Inc.公司简介:Reviva Pharmaceuticals Holdings Inc 是一家临床阶段的制药公司,致力于发现、开发疾病治疗药物并寻求将其商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403260123517a4eed4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403260123517a4eed4b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421824742","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 临近收盘快速上涨5.07%报2.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421824742","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421824742?lang=zh_cn&edition=full","pubTime":"2024-03-23 04:00","pubTimestamp":1711137607,"startTime":"0","endTime":"0","summary":"北京时间2024年03月23日04时00分,Reviva Pharmaceuticals Holdings, Inc.股票出现异动,股价大幅拉升5.07%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中,整体跌幅为0.10%。其相关个股中,Invivyd, Inc.、Virios Therapeutics, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大,Outlook Therapeutics, Inc.、Adial Pharmaceuticals, Inc、180 Life Sciences Corp.较为活跃,换手率分别为97.00%、77.67%、45.87%,振幅较大的相关个股有Virios Therapeutics, Inc.、Moolec Science Sa C/Wts 、Matinas Biopharma Holdings, Inc.,振幅分别为86.19%、75.83%、66.00%。Reviva Pharmaceuticals Holdings, Inc.公司简介:Reviva Pharmaceuticals Holdings Inc 是一家临床阶段的制药公司,致力于发现、开发疾病治疗药物并寻求将其商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240323040007861e0816&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240323040007861e0816&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421778076","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 股价大跌5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421778076","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421778076?lang=zh_cn&edition=full","pubTime":"2024-03-21 00:36","pubTimestamp":1710952596,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日00时36分,Reviva Pharmaceuticals Holdings, Inc.股票出现异动,股价快速下挫5.28%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中,整体跌幅为1.00%。其相关个股中,Xtl生物制药、Brainstorm Cell Therapeutics Inc.、Annovis Bio, Inc.涨幅较大,Xtl生物制药、Jaguar Health, Inc.、Tc Biopharm Plc较为活跃,换手率分别为158.39%、79.74%、42.96%,振幅较大的相关个股有Xtl生物制药、Igc Pharma, Inc.、Brainstorm Cell Therapeutics Inc.,振幅分别为157.69%、40.98%、39.33%。Reviva Pharmaceuticals Holdings, Inc.公司简介:Reviva Pharmaceuticals Holdings Inc 是一家临床阶段的制药公司,致力于发现、开发疾病治疗药物并寻求将其商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321003636791bc2f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321003636791bc2f5&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.revivapharma.com","stockEarnings":[{"period":"1week","weight":-0.107},{"period":"1month","weight":-0.4781},{"period":"3month","weight":-0.6116},{"period":"6month","weight":-0.5835},{"period":"1year","weight":-0.7788},{"period":"ytd","weight":-0.6757}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Reviva Pharmaceuticals Holdings, Inc.于2018年3月20日在英属维尔京群岛注册成立。该公司是一家后期制药公司,致力于发现、开发并寻求将下一代治疗方法商业化,以治疗那些对社会、患者及其家庭具有重大未满足医疗需求和负担的疾病。他们目前的产品线主要集中在中枢神经系统、炎症和心脏代谢疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.098543},{"month":2,"riseRate":0.666667,"avgChangeRate":0.042085},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.036619},{"month":4,"riseRate":0.666667,"avgChangeRate":0.052946},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.140625},{"month":6,"riseRate":0.4,"avgChangeRate":-0.085715},{"month":7,"riseRate":0,"avgChangeRate":-0.179606},{"month":8,"riseRate":0.6,"avgChangeRate":0.506015},{"month":9,"riseRate":0.4,"avgChangeRate":-0.0183},{"month":10,"riseRate":0.6,"avgChangeRate":0.261078},{"month":11,"riseRate":0.5,"avgChangeRate":-0.032114},{"month":12,"riseRate":0.666667,"avgChangeRate":0.01748}],"exchange":"NASDAQ","name":"Reviva Pharmaceuticals Holdings, Inc.","nameEN":"Reviva Pharmaceuticals Holdings, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Reviva Pharmaceuticals Holdings, Inc.(RVPH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Reviva Pharmaceuticals Holdings, Inc.(RVPH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Reviva Pharmaceuticals Holdings, Inc.,RVPH,Reviva Pharmaceuticals Holdings, Inc.股票,Reviva Pharmaceuticals Holdings, Inc.股票老虎,Reviva Pharmaceuticals Holdings, Inc.股票老虎国际,Reviva Pharmaceuticals Holdings, Inc.行情,Reviva Pharmaceuticals Holdings, Inc.股票行情,Reviva Pharmaceuticals Holdings, Inc.股价,Reviva Pharmaceuticals Holdings, Inc.股市,Reviva Pharmaceuticals Holdings, Inc.股票价格,Reviva Pharmaceuticals Holdings, Inc.股票交易,Reviva Pharmaceuticals Holdings, Inc.股票购买,Reviva Pharmaceuticals Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Reviva Pharmaceuticals Holdings, Inc.(RVPH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Reviva Pharmaceuticals Holdings, Inc.(RVPH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}